The defining feature of leukemia is the uncontrolled, malignant proliferation of leukocytes that fills and crowds the bone marrow. This rapid expansion disrupts normal hematopoiesis, so patients commonly develop anemia from reduced red blood cell production and often have low platelets due to marrow crowding. The 핵 event isn’t just a decrease in one cell line—it’s the overgrowth of abnormal white cells that suppresses all normal blood cell formation. Options that talk about increased platelets or a general hypercoagulable state aren’t the defining hallmark, and describing it as “decreased red blood cell production only” misses the central process of leukemic leukocytes overtaking the marrow and altering multiple cell lines.

Autoantibodies against the nicotinic acetylcholine receptor at the neuromuscular junction cause myasthenia gravis. When these antibodies bind the receptors, they promote receptor internalization and activate complement, reducing the number of functional ACh receptors on the postsynaptic membrane. With fewer receptors, the end-plate potential is less likely to reach threshold, so muscle fibers fail to fire reliably, especially with repeated use. That produces the hallmark pattern of fatigable weakness, often starting with ptosis and diplopia and progressing to proximal muscle weakness. Symptoms typically vary throughout the day and improve with rest; they also respond to acetylcholinesterase inhibitors that increase acetylcholine availability at the junction and to immunomodulatory therapies, with a frequent association to thymic abnormalities. For context, the other conditions involve different mechanisms: Lambert-Eaton syndrome features antibodies against presynaptic calcium channels, reducing acetylcholine release and sometimes showing improvement with activity; multiple sclerosis is a CNS demyelinating disease; Guillain-Barré syndrome is an autoimmune peripheral neuropathy affecting nerve myelin or axons.

The fundamental process in ARDS disorders is a massive inflammatory reaction in the lungs. When the alveolar-capillary membrane is injured, inflammatory mediators recruit neutrophils and other immune cells, amplifying damage and increasing capillary permeability. This inflammatory assault lets protein-rich fluid flood the alveolar spaces, impairing gas exchange and leading to diffuse alveolar damage. That inflammatory cascade is what underpins ARDS across different triggers, so inflammation is the best overall descriptor. Edema occurs as a consequence of the permeability changes, not the initiating feature, and fibrosis or purulent exudate are not universal across all ARDS cases.

Fibromyalgia centers on widespread pain with heightened sensitivity to pressure, especially at specific tender points. The hallmark is pain provoked by palpation at these sites, which people with fibromyalgia experience across multiple areas of the body. This is why the answer describing trigger/tender point pain best fits fibromyalgia. Other options reflect findings more typical of different conditions. Widespread joint inflammation with erosions points to inflammatory arthropathies like rheumatoid arthritis, which involve true joint inflammation and structural damage rather than the diffuse, noninflammatory pain pattern seen in fibromyalgia. Localized muscle spasms aren’t the defining feature of fibromyalgia, and generalized numbness isn’t the characteristic presentation—though some patients may experience sensory disturbances, it isn’t the central, defining symptom. In contrast, widespread tender point pain captures the core pattern of how fibromyalgia presents and is evaluated.